• Non ci sono risultati.

Leptin identification and quantification in human and bovine milk and infant formulas

N/A
N/A
Protected

Academic year: 2021

Condividi "Leptin identification and quantification in human and bovine milk and infant formulas"

Copied!
2
0
0

Testo completo

(1)

22 July 2021

AperTO - Archivio Istituzionale Open Access dell'Università di Torino

Original Citation:

Leptin identification and quantification in human and bovine milk and infant formulas

Terms of use: Open Access

(Article begins on next page)

Anyone can freely access the full text of works made available as "Open Access". Works made available under a Creative Commons license can be used according to the terms and conditions of said license. Use of all other works requires consent of the right holder (author or publisher) if not exempted from copyright protection by the applicable law. Availability:

This is the author's manuscript

(2)

Leptin identification and quantification in human milk and infant formulas

Claudio Medana, Federica Dal Bello, Valentina Santoro, Michael Zorzi, Daniela Gastaldi, Riccardo Aigotti

Department of Molecular Biotechnology and Health Sciences, University of Turin, via P. Giuria 5 , 10125 Torino – Italy

E-mail: claudio.medana@unito.it

OVERWIEW

References: 1) J.M. Friedman, J.L. Halaas. Leptin and the regulation of body weight in mammals. Nature, 395, 763 (1998)

2) F. Savino, A. Sardo, L. Rossi, S. Benetti, A. Savino and L. Silvestro. Mother and Infant Body Mass Index, Breast Milk Leptin and Their Serum Leptin Values. Nutrients, 8, 383 (2016)

3) Y. Wang, J.S. Heilig. Differentiation and quantification of endogenous and recombinant-methionyl human leptin in clinical plasma samples by immunocapture/mass spectrometry. J. Pharm. Biomed. Anal. 70, 440 (2012)

Figure 1: MS/MS: m/z 1244, z=13 Figure 4: natural human leptin primary sequence with digestion peptides used for quantification in evidence F8: Phenazone ESI main fragmentation pathways F9: Phenazone D1, D2, D3 ammonia/methyl losses

INTRODUCTION

Leptin is a small protein (16 KDa) present in plasma and milk. It plays a key role in the regulation of body weight and its concentration is affected by many physio-pathological parameters especially body weight variation

and lipodystrophic conditions1. Leptin is encoded by the obesity gene on

human chromosome 7 and it is mainly secreted by adipocytes. It is possible that serum leptin concentration in breastfed infants is associated to early adipose tissue production and to the leptin levels in

milk2. In order to understand the role of different newborn feeding

(breastmilk, formulas, bovine milk) on infant leptin production and risk of obesity, we aimed to develop a selective nLC-HRMS method to evaluate leptin content in different milk matrices.

Quantitation of leptin after hydrolysis

The sample eluted from immunoaffinity columns was digested in order to detect marker peptides.

Sample preparation: digestion with Trypsin. Make up 200 mM dithiotreitol (DTT) in 50 mM ammonium

bicarbonate for reduction step. Add 2.1 µL of DTT, heat solution at 60°C for 15 minutes. Remove from heat and cool for 5 minutes. Make up a 200 mM iodoacetamide (IAM) in 50mM ammonium bicarbonate for alkylation step. Add 4.4 µl of IAM and incubate the solution in the dark at room temperatures for 30 minutes. Add 2.5 µl of Trypsin solution (1 µg µL-1). Digest overnight at 37°C.

LC: Thermo Ultimate 3000 nano, column: Accucore C4 2,6 µm, 150 Å, 75 µm x 15 cm column, HCOOH

0.1% in water - HCOOH 0.1% in ACN/H2O gradient 95:5-1:99 in 98’, 0.3 µL min-1, injection volume : 1 µL

ESI MS: Thermo Orbitrap Fusion with Easy-nanoLC source, FM and data dependent analysis acquisition.

Human milk and infant formulas were provided from local pediatric hospital. In order to detect leptin concentrations < 0.1 fM, immunoaffinity extraction was performed (Experim., meth 1).

Intact leptin was not identified neither in breast milk nor in infant formulas, so the purified samples were subjected to trypsin digestion (Experim., meth 2).

Leptin quantitation in breast milk samples by MS/MS quantitation of m/z 708 ion: Sample A: 7.1 µg mL-1;

Sample B: 6.3 µg mL-1

Leptin quantitation in infant formula samples by MS/MS quantitation of m/z 708 ion: Sample C < LLOQ; Sample D: < LLOQ.

Perspectives: to perform intact protein quantitation by enhancing method 1 sensitivity and by

optimizing analyte protein immunoaffinity extraction.

Evaluation of leptin in breast milk and commercial infant formulas

The LC-HR MS and HR MS/MS behavior of leptin was evaluated by

the use of a Orbitrap Fusion tribrid analyzer. Bottom-up and top-down approaches were compared.

• We aimed to quantify leptin in human milk and infant formulas, so

an immunoaffinity extraction was performed in comparison with direct detection.

• The protein analyte was detected in human milk at 6-7 µg L-1.

Top-down characterization and quantitation of intact leptin

DISCUSSION

CONCLUSIONS

At first human leptin as intact protein was extensively characterized by high resolution mass spectrometry in order to evaluate interferences. Full MS and CID/ETD MS/MS spectra (Figure 1) of multicharged positive ions of standard proteins were acquired. A top-down approach was used with the aim of reduce to a minimum sample manipulation. Accuracy, precision, LLOQ and linearity were then assessed. After immunoaffinity extraction in the samples analyzed (both human milk and infant formulas samples) an intense protein signal different from leptin was detected. After digestion of the immunoaffinity purified samples both qualifier (m/z 764) and quantifier (m/z 708) peptides from leptin were identified. These peptides were specifically calibrated using digested standard leptin (Figure 4).

AP

PL

IC

AT

IO

N

TO

M

IL

K

SAM

PL

ES

TO

P-DO

W

N

L

C-MS

BO

TT

O

M

-UP

L

C-MS

LLOQ 175 ng mL-1 (175 pg on-column); linearity 175-1000 ng mL-1

Experimental

:

Leptin evaluation in real samples:

Figure 6: chromatogram of a digested breast milk sample

CID

ETD

INDISHTQSVSS

m/z 708, z = 2

NVIQISNDLENLR

m/z 764, z = 2

m/z 708, z = 2 y = 24248x - 4E+06 R² = 0,99711 0,00E+00 2,00E+07 4,00E+07 6,00E+07 8,00E+07 1,00E+08 1,20E+08 1,40E+08 0 1000 2000 3000 4000 5000 6000 Ar ea Concentration (µg/mL)

After digestion of purified samples leptin was quantified in samples (besides identification of interfering unknown proteins: lactoferrin and β-lactoglobulin). The method was applied to investigate about the presence of leptin in two different commercial infant formulas. In this kind of food supplements leptin resulted < LLOQ (1 µg/L).

Finally leptin concentration was quantified in human breast milk samples, obtaining values of 6-7 µg/L.

The developed method displays a better sensitivity compared to

literature3 and can be used for milk and plasma leptin dosage.

Data acquisition of new samples for statistical purposes is being implemented.

MHWGTLCGFLWLWPYLFYVQAVPIQK

VQDDTKTLIKTIVTR

INDISHTQSVSS

K

QKVTGLDFIPGLHPILTLSKMDQTLAV

YQQILTSMPSR

NVIQISNDLENLR

DL

LHVLAFSKSCHLPWASGLETLDSLGGVL

EASGYSTEVVALSRLQGSLQDMLWQLD

LSPGC

The human milk was prepared and purified following a immunoaffinity protocol in order to detect leptin as intact protein.

Sample preparation: purification of human milk with glycoLink micro immobilization kit and monoclonal

antilep antibody (Sigma Aldrich). Make up 2,5 µL of antilep antibody in 97,5 µL of glikolink coupling buffer and add 11 µL of NaIO4 0.1 M for desalting step. Bind the antilep antibody to the column resin and equilibrate this latter with a pH 7-8 PBS buffer. Incubate overnight at 4°C 250 µL of human milk with binded antilep antibody. Elute analyte (leptin protein) with glicine HCl solution pH 2.5-3 0.2 M and neutralize the eluating with tris buffer 1M pH 8.5-9.

LC: Thermo Ultimate 3000 nano, column: Pepmap C18 2 µm, 100 Å, 75 µm x 25 cm column, HCOOH 0.1% in

water - HCOOH 0.1% in ACN/H2O 80/20 gradient 95:5-10:90 in 25’, 0.3 µL min-1, injection volume : 1 µL.

MS: Thermo Orbitrap Fusion with Easy-nanoLC source, FM and MS2 acquisition.

RT:9.66 - 114.01 SM:11G 10 20 30 40 50 60 70 80 90 100 110 Time (min) 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 R e la tive A b u n d a n ce 46.56 79.69 71.01 43.94 53.99 27.28 31.01 62.20 47.14 39.00 58.36 14.85 24.91 37.76 50.59 78.63 67.81 85.5889.56 101.28 106.11 NL: 1.45E9 TIC F: FTMS + p NSI Full ms [200.0000-2000.0000] MS C3_LatteMaterno_Orl andini_DIG RT:9.92 - 114.63 SM:11G 10 20 30 40 50 60 70 80 90 100 110 Time (min) 0 10 20 30 40 50 60 70 80 90 100 R e la tive A b u n d a n ce 28.81 33.77 46.61 79.68 45.02 26.74 22.36 71.07 20.42 19.29 37.51 62.39 47.26 43.35 50.69 54.21 104.96 99.12 57.80 64.48 89.70 106.12 78.40 88.17 96.62 NL: 1.09E9 TIC F: FTMS + p NSI Full ms [200.0000-2000.0000] MS C2_Mellin0nascita _DIG

Leptin_1ppm_001 #2402RT:15.84AV:1NL:4.24E6

F:FTMS + p NSI Full ms [700.0000-2000.0000] 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900 2000 m/z 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 R e la tive A b u n d a n ce 1154.8934 z=14 1243.7307 z=13 1077.9672 z=15 1347.2076 z=12 1010.7189 z=16 1469.7706 z=11 1795.9415 z=9 1616.6454 z=10 758.2188 z=1 951.2061 z=? 832.2368 z=1 1199.7556z=? 1723.0992z=? 1267.4291 z=? 1954.1998 z=? 1665.1259 z=? 1815.9998 z=? 1537.3066 z=? 1491.2700 z=? 1436.4917 z=? 1587.3596 z=? 1369.9572 z=? RT:0.00 - 35.01SM:7G 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 Time (min) 0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 R el at ive A bu nd an ce 15.84 16.56 14.26 6.12 7.41 5.85 13.84 3.68 9.17 11.22 17.5018.5020.95 23.74 27.7329.26 29.6930.11 31.61 1.79 NL: 4.78E7 m/z= 1010.20-1011.20+1077.50-1078.50+ 1154.40-1155.40+1243.20-1244.20+ 1346.70-1347.70+1469.30-1470.30+ 1615.90-1616.90+1795.40-1796.40 F: FTMS + p NSI Full ms [700.0000-2000.0000] MS Leptin_1ppm_001 LLOQ 100 ng mL-1 (100 pg on-column); linearity 175-5000 ng mL-1

Figure 2: intact leptin chromatogram and full-Ms spectrum at 1000 ng mL-1 y = 617041x - 1E+08 R² = 0,98509 0,00E+00 1,00E+08 2,00E+08 3,00E+08 4,00E+08 5,00E+08 6,00E+08 0 200 400 600 800 1000 1200 TIC Figure 3: MS/MS fragmentation of standard recombinant methionyl human leptin, MVPIQKVQDDTKTLIKTIVTRINDISHTQSV SSKQKVTGLDFIPGLHPILTLSKMDQTLAVY QQILTSMPSRNVIQISNDLENLRDLLHVLAF SKSCHLPWASGLETLDSLGGVLEASGYSTE VVALSRLQGSLQDMLWQLDLSPGC

Figure 5: chromatograms and MS/MS spectra of m/z 708 and 764 ions

Figure 7: chromatogram of a digested infant

formula sample Figure 8: extracted chromatograms of m/z 708 and 764 ions: Breast milk vs. two different infant formula samples

Experimental

Riferimenti

Documenti correlati

Lamberti C, Bordiga S, Bonino F, Prestipino C, Berlier G, Capello L, D'Acapito F, Llabrés i Xamena FX, Zecchina A (2003) Determination of the oxidation and coordination state of

Tuttavia, va sottolineato come tali forme di sottile resistenza non sfocino mai in una critica aperta o in una presa di posizione netta, giocata sul piano dell’ufficialità politica:

In this case it is possible to prove that if the generic element is identifiable, then the set of all real points with that rank is dense for the euclidean topology (see Theorem

This trend may also offer opportunities for innovation in spatial planning since users are offering through social media petabytes of freely and publicly available

Si tratta, tuttavia, di un legame formale dato che solo il Piano Territoriale della Regione Campania ha previsto la costituzione di distretti culturali in chiave turistica

This includes: Scopus (Elsevier), MEDLINE / PudMed, Science Citation Index (Web of Science), ProQuest Psychology Journals, ScienceDirect Journals (Elsevier),

In the first part of my work I have focused on the identification and characterization of the kinase/phosphatase pair involved in the high light

Nelle regioni più deboli la costruzione in terra è la tecnologia più ef- ficace e sostenibile per produrre a breve termine volumi consistenti di abitazioni ed edifici in